Century Therapeutics (NASDAQ:IPSC – Get Free Report) had its target price cut by stock analysts at Piper Sandler from $12.00 to $4.00 in a research report issued on Monday,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback